Sign up for FlowVella
Sign up with FacebookAlready have an account? Sign in now
By registering you are agreeing to our
Terms of Service
Loading Flow
一项头对头比较替格瑞洛与氯吡格雷在急性冠脉综合征(ACS)中应用的研究-PLATO(抑制血小板与患者转归)研究结果显示:
替格瑞洛是可显著降低ACS患者病死率的药物并且在减少心血管事件的同时不伴随大出血增加。
CONCLUSION
